Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 13Lymphoma 6Lymphoma, T-Cell, Peripheral 4Lymphoma, Non-Hodgkin 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell 3Leukemia, Myeloid, Acute 3Waldenstrom Macroglobulinemia 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Sarcoma 1Primary Myelofibrosis 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Hematologic Neoplasms 1Glioma 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 5Filgrastim 5Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiotherapy 3Radiotherapy, Intensity-Modulated 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2Etoposide 2Drug Therapy 2Cyproheptadine 2Carmustine 2Carboplatin 2Bortezomib 2vorasidenib 1vocimagene amiretrorepvec 1varlilumab 1trametinib 1sonidegib 1selinexor 1sargramostim 1romidepsin 1ribociclib 1poly ICLC 1ixabepilone 1ispinesib 1imetelstat 1exatecan 1etoposide phosphate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × selinexor × Lymphoid × Clear all
NCT02323880 2025-01-14

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Children's Oncology Group

Phase 1 Completed
59 enrolled 20 charts
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioma, Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡